These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28395400)

  • 61. Factors associated with treatment for latent tuberculosis in persons living with HIV/AIDS.
    Aquino DS; Moura LC; Maruza M; Silva AP; Ximenes RA; Lacerda HR; Miranda Filho Dde B; Albuquerque Mde F
    Cad Saude Publica; 2015 Dec; 31(12):2505-13. PubMed ID: 26872227
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
    Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Policy recommendation: latent tuberculosis infection screening and treatment in children in immigration detention.
    Krause V;
    Commun Dis Intell Q Rep; 2015 Dec; 39(4):E597-8. PubMed ID: 26779733
    [No Abstract]   [Full Text] [Related]  

  • 64. Postarrival Tuberculosis Screening of High-Risk Immigrants at a Local Health Department.
    Nuzzo JB; Golub JE; Chaulk P; Shah M
    Am J Public Health; 2015 Jul; 105(7):1432-8. PubMed ID: 25602872
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Update in tuberculosis and nontuberculous mycobacterial disease 2011.
    Nahid P; Menzies D
    Am J Respir Crit Care Med; 2012 Jun; 185(12):1266-70. PubMed ID: 22707733
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Recent latent tuberculous infection (LTBI) in different sub-groups of contacts].
    Fournier A; Antoun F; Larnaudie S
    Rev Mal Respir; 2012 Nov; 29(9):1079-87. PubMed ID: 23200579
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Viral hepatitis prevalence in patients with active and latent tuberculosis.
    Nooredinvand HA; Connell DW; Asgheddi M; Abdullah M; O'Donoghue M; Campbell L; Wickremasinghe MI; Lalvani A; Kon OM; Khan SA
    World J Gastroenterol; 2015 Aug; 21(29):8920-6. PubMed ID: 26269682
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Specificity of the tuberculin skin test and the T-SPOT.TB assay among students in a low-tuberculosis incidence setting.
    Talbot EA; Harland D; Wieland-Alter W; Burrer S; Adams LV
    J Am Coll Health; 2012; 60(1):94-6. PubMed ID: 22171735
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of the T-SPOT.TB assay to screen latent tuberculosis infection among the TB contacts in Shanghai, China.
    Hu Y; Zhao Q; Graviss EA; Jiang W; Yuan Z; Xu B
    J Infect; 2012 Jul; 65(1):39-48. PubMed ID: 22484244
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Compliance with postexposure screening and treatment of latent tuberculosis infection among healthcare workers in a tertiary care hospital in Saudi Arabia.
    Balkhy HH; Miller TL; Ali S; Nuzzo JB; Kentenyants K; El-Saed A; McNabb SJ
    Infect Control Hosp Epidemiol; 2014 Feb; 35(2):176-81. PubMed ID: 24442081
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Moving toward tuberculosis elimination: implementation of statewide targeted tuberculin testing in Tennessee.
    Cain KP; Garman KN; Laserson KF; Ferrousier-Davis OP; Miranda AG; Wells CD; Haley CA
    Am J Respir Crit Care Med; 2012 Aug; 186(3):273-9. PubMed ID: 22561962
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Present-day treatment of tuberculosis and latent tuberculosis infection.
    Pérez-Camacho I; Rivero-Juárez A; Kindelán JM; Rivero A
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():41-6. PubMed ID: 21420566
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Screening for Latent Tuberculosis (TB) Infection in Low TB Incidence Countries.
    van der Werf MJ; Rosales-Klintz S; de Vlas SJ
    Clin Infect Dis; 2020 Feb; 70(4):716-717. PubMed ID: 31161216
    [No Abstract]   [Full Text] [Related]  

  • 74. Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease.
    ; Milburn H; Ashman N; Davies P; Doffman S; Drobniewski F; Khoo S; Ormerod P; Ostermann M; Snelson C
    Thorax; 2010 Jun; 65(6):557-70. PubMed ID: 20522863
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Suggestions for the promotion of evidence-based public health in South Korea.
    Bae JM
    Epidemiol Health; 2017; 39():e2017030. PubMed ID: 28728346
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Testing Healthcare Workers for Latent Tuberculosis: Is It Evidence Based, Bio-Plausible, Both, Or Neither?
    Gill J; Prasad V
    Am J Med; 2019 Nov; 132(11):1260-1261. PubMed ID: 30946831
    [No Abstract]   [Full Text] [Related]  

  • 77. Better data to drive more effective care for people with latent tuberculosis infection in Canada.
    Essue BM; Milinkovic D; Birch S
    CMAJ; 2018 Jun; 190(23):E700-E701. PubMed ID: 29891473
    [No Abstract]   [Full Text] [Related]  

  • 78. Deployment-related testing and treatment for latent tuberculosis infection, Part I.
    Mancuso JD; Keep LW
    Mil Med; 2011 Aug; 176(8):865-9. PubMed ID: 21882774
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tuberculosis prevention and care in Korea: Evolution of policy and practice.
    Go U; Park M; Kim UN; Lee S; Han S; Lee J; Yang J; Kim J; Park S; Kim Y; Yoo H; Cha J; Park W; Kang H; Kim H; Park G; Kim M; Park O; Son H; Cho E; Na K; Kwon Y; Lee Y; Lee KH; Jeong E; Lee D; Yang BG; Jeon BY; Lee JK;
    J Clin Tuberc Other Mycobact Dis; 2018 May; 11():28-36. PubMed ID: 31720389
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Latent tuberculosis infection sreening and preventive therapy in students].
    Chen W; Cheng S
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jan; 39(1):21-4. PubMed ID: 27264574
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.